Blood tests in development for Alzheimer’s disease rely on Aβ and phosphorylated tau, markers of its hallmark pathologies. While powerful, these markers are only accurate in about 90 percent of cases.

Invitrogen ProcartaPlex and QuantiGene Plex assays offer the unique ability of a multi-omics high-throughput approach by utilizing the Luminex platform. Genomic and proteomic workflows can be combined ...

Please provide your email address to receive an email when new articles are posted on . Use of a transforming growth factor-beta pathway-based combinatorial serum protein panel may aid in the early ...